{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:40:41Z","timestamp":1761093641517,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bcmd.2013.05.007","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T14:48:26Z","timestamp":1371134906000},"page":"162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel pattern of uridine diphosphate glucuronosyltransferase polymorphisms associated with hyperbilirubinemia during nilotinib treatment"],"prefix":"10.1016","volume":"51","author":[{"given":"Claudio","family":"Fozza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Coiana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Rosatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Longinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2013.05.007_bb0005","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa055104","article-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL","volume":"354","author":"Kantarjian","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2013.05.007_bb0010","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/sj.leu.2404827","article-title":"UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia","volume":"21","author":"Singer","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2013.05.007_bb0015","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.leukres.2009.04.013","article-title":"Nilotinib-induced hyperbilirubinemia: is it a negligible adverse event?","volume":"33","author":"Kim","year":"2009","journal-title":"Leuk. Res."},{"year":"2003","series-title":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE) Bethesda","author":"National Cancer Institute","key":"10.1016\/j.bcmd.2013.05.007_bb0020"},{"key":"10.1016\/j.bcmd.2013.05.007_bb0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00280-010-1445-3","article-title":"The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1","volume":"67","author":"Fujita","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcmd.2013.05.007_bb0030","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1373\/clinchem.2005.055681","article-title":"The polymorphism c.\u20133279T>G in the phenobarbital-responsive enhancer module of the bilirubin UDP-glucuronosyltransferase gene is associated with Gilbert syndrome","volume":"51","author":"Costa","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bcmd.2013.05.007_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/gte.2006.10.121","article-title":"Combined test for UGT1A1\u22123279T\u2212>G and A(TA)nTAA polymorphisms best predicts Gilbert's syndrome in Italian pediatric patients","volume":"10","author":"Ferraris","year":"2006","journal-title":"Genet. Test."},{"key":"10.1016\/j.bcmd.2013.05.007_bb0040","first-page":"98","article-title":"Does bilirubin level correspond to interaction of c.\u22123279T>G and A(TA)7TAA variants in UGT1A1 gene?","volume":"55","author":"Slachtova","year":"2009","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.bcmd.2013.05.007_bb0045","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bcmd.2012.01.004","article-title":"Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects","volume":"48","author":"Rodrigues","year":"2012","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613001204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613001204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:29:36Z","timestamp":1761049776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979613001204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1079979613001204"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.05.007","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel pattern of uridine diphosphate glucuronosyltransferase polymorphisms associated with hyperbilirubinemia during nilotinib treatment","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}